NEW YORK, Feb. 9, 2025 /PRNewswire/ -- "The announcement from the National Institutes of Health (NIH) that they are dramatically reducing funding for indirect costs for research grants is a threat to research that will disrupt critical medical advances. Funding for indirect costs is essential funding because it pays for the infrastructure that is required to make research possible.
This cut will significantly decrease the federal funding that research institutions receive to conduct critical type 1 diabetes (T1D) research. This includes grants funded by the Special Diabetes Program.
The decades of strong Federal support for T1D research have paid immense dividends. Developing cures requires that strong support to continue. This action is a step backward that hurts not only T1D research and the 1.6 million Americans living with T1D but also research for many other diseases. The impacts will be vast and far-reaching.
We are working with legislators and key decision makers to express our deep concerns and ensure they understand the impact of this decision and any actions that undermine or delay reaching cures."
About Breakthrough T1D, Formerly JDRF
As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.
Media Contact:
Chelsea-Lyn Rudder
646-946-0513
SOURCE Breakthrough T1D, Formerly JDRF